IXUS Among Ex-US Broad ETFs
175 Ex-US broad ETFs by Max
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +0.9% | −0.5% | −1.3% | −4.7% | +11.8% | +14.1% | +70.0% | +47.4% | +181.6% |
| Peer average | +0.2% | −1.1% | −0.4% | −4.3% | +10.3% | +13.2% | +67.3% | +48.0% | — |
| S&P 500 · VOO | +1.3% | −0.9% | −2.4% | −2.1% | +12.3% | +12.8% | +81.3% | +75.3% | — |
$41 of every $1,000 in IXUS is Taiwan
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | 2330.TWTaiwan Semiconductor Manufacturing | Technology | 4.14% | $414.03 | 34.4M | $2.39B |
| 2 | 005930.KSSamsung Electronics | Technology | 1.69% | $169.05 | 6.6M | $974.8M |
| 3 | ASML.ASAsml | Technology | 1.43% | $143.04 | 543K | $824.9M |
| 4 | 000660.KSSK Hynix | Technology | 1.22% | $121.54 | 773K | $700.9M |
| 5 | ROP.SWRoche PS PAR AG | Healthcare | 0.83% | $82.98 | 984K | $478.5M |
| 6 | 0700.HKTencent | Communication Services | 0.79% | $79.10 | 8.6M | $456.2M |
| 7 | HSBA.LHsbc | Financial Services | 0.74% | $74.11 | 23.9M | $427.4M |
| 8 | NOVN.SWNovartis AG | Healthcare | 0.72% | $72.39 | 2.6M | $417.5M |
| 9 | RY.TORoyal Bank OF Canada | Financial Services | 0.68% | $67.96 | 1.9M | $391.9M |
| 10 | AZN.LAstrazeneca | Healthcare | 0.68% | $67.52 | 2.1M | $389.3M |
| 11 | SHEL.LShell | Energy | 0.68% | $67.50 | 8.1M | $389.3M |
| 12 | NESN.SWNestle | Consumer Defensive | 0.65% | $65.33 | 3.6M | $376.7M |
| 13 | SAP.DESAP | Technology | 0.58% | $57.78 | 1.4M | $333.2M |
| 14 | 8306.TMitsubishi UFJ Financial Group | Financial Services | 0.56% | $55.84 | 14.9M | $322.0M |
| 15 | SIE.DESiemens N AG | Industrials | 0.54% | $53.51 | 1.0M | $308.6M |
of the $671B in 175 Ex-US broad ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | 2330.TW | Taiwan Semiconductor Manufacturing | 4.14% |
| 2 | 005930.KS | Samsung Electronics | 1.69% |
| 3 | ASML.AS | Asml | 1.43% |
| 4 | 000660.KS | SK Hynix | 1.22% |
| 5 | ROP.SW | Roche PS PAR AG | 0.83% |
| 6 | 0700.HK | Tencent | 0.79% |
| 7 | HSBA.L | Hsbc | 0.74% |
| 8 | NOVN.SW | Novartis AG | 0.72% |
| 9 | RY.TO | Royal Bank OF Canada | 0.68% |
| 10 | AZN.L | Astrazeneca | 0.68% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Jun 15, 2026 | Jun 18, 2026 | $1.23 |
| Dec 16, 2025 | Dec 19, 2025 | $1.57 |
| Jun 16, 2025 | Jun 20, 2025 | $1.17 |
| Dec 17, 2024 | Dec 20, 2024 | $1.18 |
| Jun 11, 2024 | Jun 17, 2024 | $1.02 |
| Dec 20, 2023 | Dec 27, 2023 | $1.05 |
| Jun 7, 2023 | Jun 13, 2023 | $0.98 |
| Dec 13, 2022 | Dec 19, 2022 | $0.49 |
| Jun 9, 2022 | Jun 15, 2022 | $0.95 |
| Dec 30, 2021 | Jan 5, 2022 | $0.0860 |
| Dec 13, 2021 | Dec 17, 2021 | $1.27 |
| Jun 10, 2021 | Jun 16, 2021 | $0.85 |